Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.

ConditionCirrhosis

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-80

SponsorZhujiang Hospital

About this trial

To investigate the association between lactate-mediated alterations in the gut microbiota and disease progression in patients with liver cirrhosis; and to examine the correlations of lactate levels among serum, fecal, and tissue samples in patients with liver cirrhosis.

Eligibility criteria

Qualifiers

None

Disqualifiers

1. A history of severe organic diseases involving the liver, gastrointestinal tract, kidneys, or other organ systems; malignant tumors; or autoimmune diseases.

Trial design

Treatments tested in this trial

observational study, no intervention

Treatment groups

200 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Zhujiang Hospital

Lead sponsor

Source ClinicalTrials.gov